Wednesday, November 5, 2025
HomeIndustriesBiotechnology

Biotechnology

FDA Approves Genentech’s Vabysmo Prefilled Syringe (PFS) for Three Leading Causes of Vision Loss

Genentech, a member of the Roche Group announced the U.S. Food and Drug Administration (FDA) has approved the Vabysmo (faricimab-svoa) 6.0 mg single-dose prefilled...

Read Magazine’s Weekly Roundup: Discover the Most Recent News Stellantis, Amerant Bank, Siemens, SIXGEN, Sivers Semiconductors and More !

Here is Read Magazine’s Weekly Roundup of the top news from global markets. In this fast-paced world, breaking down information helps readers grasp the...

Accomplished Biotech Leader Michel Dahan Joins Alkeus as President and CEO

Alkeus Pharmaceuticals, Inc. announced that Michel Dahan has joined the company as President and Chief Executive Officer and will be responsible for leading the...

ANI Pharmaceuticals Announces the FDA Approval and Launch of Naproxen Delayed-Release Tablets, USP

ANI Pharmaceuticals, Inc. announced that it received U.S. Food and Drug Administration (FDA) approval for the Abbreviated New Drug Application (ANDA) and launched Naproxen...

Boehringer Ingelheim and OSE Immunotherapeutics advance clinical development of first-in-class SIRP cancer immunology treatment BI 770371

Boehringer Ingelheim and OSE Immunotherapeutics SA (OSE), a clinical stage biotech company, announced that Boehringer will be progressing their first-in-class SIRPα immuno-oncology program into...
0FansLike
0FollowersFollow
spot_img

Hot Topics